CNB Bank’s AstraZeneca AZN Stock Holding History

CNB Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-60	Closed	-$9.28K	–	528
2024 Q2	$9.28K	Hold	60	–	–	﹤0.01%	403
2024 Q1	$8.06K	Hold	60	–	–	﹤0.01%	399
2023 Q4	$8.02K	Hold	60	–	–	﹤0.01%	382
2023 Q3	$8.06K	Sell	60 -50	-45%	-$6.83K	﹤0.01%	381
2023 Q2	$15.7K	Hold	110	–	–	0.01%	302
2023 Q1	$15.2K	Hold	110	–	–	0.01%	310
2022 Q4	$14.8K	Sell	110 -41	-27%	-$5.14K	0.01%	298
2022 Q3	$17K	Sell	151 -28	-16%	-$3.55K	0.01%	286
2022 Q2	$24K	Hold	179	–	–	0.02%	261
2022 Q1	$24K	Sell	179 -114	-39%	-$13.7K	0.01%	269
2021 Q4	$34K	Sell	293 -205	-41%	-$24.1K	0.02%	247
2021 Q3	$60K	Buy	498 +448	+896%	+$52.1K	0.04%	215
2021 Q2	$6K	Hold	50	–	–	﹤0.01%	353
2021 Q1	$5K	Hold	50	–	–	﹤0.01%	348
2020 Q4	$5K	Buy	+50	New	+$5.3K	﹤0.01%	347
2019 Q3	–	Sell	-412	Closed	-$34K	–	398
2019 Q2	$34K	Sell	412 -37	-8%	-$2.9K	0.03%	251
2019 Q1	$36K	Sell	449 -91	-17%	-$7.17K	0.02%	200
2018 Q4	$41K	Buy	540 +383	+244%	+$29.9K	0.03%	175
2018 Q3	$25K	Hold	157	–	–	0.01%	189
2018 Q2	$25K	Buy	+157	New	+$11.3K	0.01%	187

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CNB Bank's AZN Position: Q3 2024 in Review

CNB Bank sold out of AstraZeneca (AZN) in Q3 2024, closing a stake of 60 shares — an estimated $9.28K sold.

CNB Bank first reported a position in AZN in Q2 2018 and held it in 20 quarters. The position peaked at $60K in Q3 2021. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

CNB Bank reported no remaining AstraZeneca position as of Q3 2024 after selling out during the quarter.
CNB Bank sold 60 AstraZeneca shares in Q3 2024, an estimated $9.28K.
CNB Bank first reported a position in AstraZeneca in Q2 2018 and held it in 20 quarters.
CNB Bank's AstraZeneca position peaked at $60K in Q3 2021.
1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on CNB Bank's 13F filing for Q3 2024, filed 18 Oct 2024.